Matches in SemOpenAlex for { <https://semopenalex.org/work/W1554789063> ?p ?o ?g. }
- W1554789063 endingPage "139" @default.
- W1554789063 startingPage "135" @default.
- W1554789063 abstract "BACKGROUND: In Canada, more than 70% of new cases of hepatitis C virus (HCV) infection per year involve injection drug users (IDUs) and, currently, there is no consensus on how to offer them medical care. OBJECTIVE: To examine the characteristics of Canadian specialist physicians and their likelihood to provide treatment to HCV patients who are IDUs. METHODS: A nationwide, cross-sectional study was conducted in the specialty areas of hepatology, gastroenterology and infectious diseases to examine HCV services. The questionnaire requested information regarding basic demographics, referral pathways and opinions (yes/no), and examined how a physician’s treatment regimen is influenced by factors such as treatment eligibility, HCV care management and barriers to providing quality service. RESULTS: Despite the fact that the majority of prevalent and incident cases of HCV are associated with injection drug use, very few specialist physicians actually provide the necessary therapy to this population. Only 19 (19.79%) comprehensive service providers were likely to provide treatment to a current IDU who uses a needle exchange on a regular basis. The majority of comprehensive service providers (n=86 [89.58%]) were likely to provide treatment to a former IDU who was stable on substitution therapy. On bivariate analysis, factors associated with the likelihood to provide treatment to current IDUs included physicians’ type, ie, infectious disease specialists compared with noninfectious specialists (OR 3.27 [95% CI 1.11 to 9.63]), and the size of the community where they practice (OR 4.16 [95% CI 1.36 to 12.71] [population 500,000 or greater versus less than 500,000]). Results of the multivariate logistic regression analysis were largely consistent with the results observed in the bivariate analyses. After controlling for other confounding variables, only community size was significantly associated with providing treatment to current IDUs (OR 3.89 [95% CI 1.06 to 14.26] [population 500,000 or greater versus less than 500,000]). CONCLUSION: The present study highlighted the reluctance of specialists to provide treatment to current IDUs infected with HCV. Providing treatment services for HCV-infected substance abusers is challenging and there are many treatment barriers. However, effective delivery of treatment to this population will help to limit the spread of HCV. The present study clearly identified a need for improved HCV treatment accessibility for IDUs." @default.
- W1554789063 created "2016-06-24" @default.
- W1554789063 creator A5015592432 @default.
- W1554789063 creator A5021981863 @default.
- W1554789063 creator A5034137506 @default.
- W1554789063 creator A5046358472 @default.
- W1554789063 creator A5077238483 @default.
- W1554789063 date "2011-01-01" @default.
- W1554789063 modified "2023-10-13" @default.
- W1554789063 title "Physicians’ Attitudes and Practice Toward Treating Injection Drug Users Infected with Hepatitis C Virus: Results from a National Specialist Survey in Canada" @default.
- W1554789063 cites W138424127 @default.
- W1554789063 cites W1525038223 @default.
- W1554789063 cites W1586867320 @default.
- W1554789063 cites W1682297861 @default.
- W1554789063 cites W1963967982 @default.
- W1554789063 cites W1965380793 @default.
- W1554789063 cites W1969473132 @default.
- W1554789063 cites W1980031893 @default.
- W1554789063 cites W1981564509 @default.
- W1554789063 cites W1982054245 @default.
- W1554789063 cites W1983041642 @default.
- W1554789063 cites W1995580832 @default.
- W1554789063 cites W2003761258 @default.
- W1554789063 cites W2023562655 @default.
- W1554789063 cites W2030239731 @default.
- W1554789063 cites W2037595198 @default.
- W1554789063 cites W2041934554 @default.
- W1554789063 cites W2046468353 @default.
- W1554789063 cites W2067415174 @default.
- W1554789063 cites W2067488588 @default.
- W1554789063 cites W2078450406 @default.
- W1554789063 cites W2081569952 @default.
- W1554789063 cites W2090720925 @default.
- W1554789063 cites W2103170730 @default.
- W1554789063 cites W2115940174 @default.
- W1554789063 cites W2124420117 @default.
- W1554789063 cites W2129683974 @default.
- W1554789063 cites W2131792659 @default.
- W1554789063 cites W2138434459 @default.
- W1554789063 cites W2161893095 @default.
- W1554789063 cites W2314619766 @default.
- W1554789063 cites W3135424305 @default.
- W1554789063 doi "https://doi.org/10.1155/2011/810108" @default.
- W1554789063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3076031" @default.
- W1554789063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21499577" @default.
- W1554789063 hasPublicationYear "2011" @default.
- W1554789063 type Work @default.
- W1554789063 sameAs 1554789063 @default.
- W1554789063 citedByCount "63" @default.
- W1554789063 countsByYear W15547890632012 @default.
- W1554789063 countsByYear W15547890632013 @default.
- W1554789063 countsByYear W15547890632014 @default.
- W1554789063 countsByYear W15547890632015 @default.
- W1554789063 countsByYear W15547890632016 @default.
- W1554789063 countsByYear W15547890632017 @default.
- W1554789063 countsByYear W15547890632018 @default.
- W1554789063 countsByYear W15547890632019 @default.
- W1554789063 countsByYear W15547890632020 @default.
- W1554789063 countsByYear W15547890632021 @default.
- W1554789063 countsByYear W15547890632023 @default.
- W1554789063 crossrefType "journal-article" @default.
- W1554789063 hasAuthorship W1554789063A5015592432 @default.
- W1554789063 hasAuthorship W1554789063A5021981863 @default.
- W1554789063 hasAuthorship W1554789063A5034137506 @default.
- W1554789063 hasAuthorship W1554789063A5046358472 @default.
- W1554789063 hasAuthorship W1554789063A5077238483 @default.
- W1554789063 hasBestOaLocation W15547890631 @default.
- W1554789063 hasConcept C126322002 @default.
- W1554789063 hasConcept C142052008 @default.
- W1554789063 hasConcept C142724271 @default.
- W1554789063 hasConcept C203014093 @default.
- W1554789063 hasConcept C20387591 @default.
- W1554789063 hasConcept C2522874641 @default.
- W1554789063 hasConcept C2776135927 @default.
- W1554789063 hasConcept C2776408679 @default.
- W1554789063 hasConcept C2776455275 @default.
- W1554789063 hasConcept C2781413609 @default.
- W1554789063 hasConcept C2908647359 @default.
- W1554789063 hasConcept C41260117 @default.
- W1554789063 hasConcept C512399662 @default.
- W1554789063 hasConcept C71924100 @default.
- W1554789063 hasConcept C99454951 @default.
- W1554789063 hasConceptScore W1554789063C126322002 @default.
- W1554789063 hasConceptScore W1554789063C142052008 @default.
- W1554789063 hasConceptScore W1554789063C142724271 @default.
- W1554789063 hasConceptScore W1554789063C203014093 @default.
- W1554789063 hasConceptScore W1554789063C20387591 @default.
- W1554789063 hasConceptScore W1554789063C2522874641 @default.
- W1554789063 hasConceptScore W1554789063C2776135927 @default.
- W1554789063 hasConceptScore W1554789063C2776408679 @default.
- W1554789063 hasConceptScore W1554789063C2776455275 @default.
- W1554789063 hasConceptScore W1554789063C2781413609 @default.
- W1554789063 hasConceptScore W1554789063C2908647359 @default.
- W1554789063 hasConceptScore W1554789063C41260117 @default.
- W1554789063 hasConceptScore W1554789063C512399662 @default.
- W1554789063 hasConceptScore W1554789063C71924100 @default.
- W1554789063 hasConceptScore W1554789063C99454951 @default.
- W1554789063 hasIssue "3" @default.